|
a |
|
b/processing/MACCROBAT/18416479.ann |
|
|
1 |
T1 Age 2 13 74-year-old |
|
|
2 |
T2 Sex 14 17 man |
|
|
3 |
T3 Clinical_event 22 30 referred |
|
|
4 |
E1 Clinical_event:T3 |
|
|
5 |
T4 Nonbiological_location 38 46 hospital |
|
|
6 |
T5 Date 50 63 November 2000 |
|
|
7 |
E2 Date:T5 |
|
|
8 |
T6 Sign_symptom 75 92 liver dysfunction |
|
|
9 |
E3 Sign_symptom:T6 |
|
|
10 |
T7 Disease_disorder 164 182 nephrotic syndrome |
|
|
11 |
E4 Disease_disorder:T7 |
|
|
12 |
T8 Date 186 190 1995 |
|
|
13 |
E5 Date:T8 |
|
|
14 |
T9 Clinical_event 111 126 medical checkup |
|
|
15 |
E6 Clinical_event:T9 |
|
|
16 |
T10 Diagnostic_procedure 192 215 Laboratory examinations |
|
|
17 |
E7 Diagnostic_procedure:T10 |
|
|
18 |
T11 Diagnostic_procedure 232 259 serum hepatobiliary enzymes |
|
|
19 |
E8 Diagnostic_procedure:T11 |
|
|
20 |
T12 Lab_value 223 231 elevated |
|
|
21 |
R1 MODIFY Arg1:T12 Arg2:E8 |
|
|
22 |
T13 Diagnostic_procedure 264 267 IgM |
|
|
23 |
E9 Diagnostic_procedure:T13 |
|
|
24 |
R2 MODIFY Arg1:T12 Arg2:E9 |
|
|
25 |
T14 Diagnostic_procedure 289 317 antimitochondrial antibodies |
|
|
26 |
E10 Diagnostic_procedure:T14 |
|
|
27 |
T15 Lab_value 277 285 presence |
|
|
28 |
R3 MODIFY Arg1:T15 Arg2:E10 |
|
|
29 |
T16 Diagnostic_procedure 341 352 Hepatitis B |
|
|
30 |
E11 Diagnostic_procedure:T16 |
|
|
31 |
T17 Diagnostic_procedure 319 336 Serologic markers |
|
|
32 |
E12 Diagnostic_procedure:T17 |
|
|
33 |
R4 SUB_PROCEDURE Arg1:E11 Arg2:E12 |
|
|
34 |
T18 Diagnostic_procedure 341 350;357 358 Hepatitis C |
|
|
35 |
E13 Diagnostic_procedure:T18 |
|
|
36 |
R5 SUB_PROCEDURE Arg1:E13 Arg2:E12 |
|
|
37 |
T19 Lab_value 372 380 negative |
|
|
38 |
R6 MODIFY Arg1:T19 Arg2:E13 |
|
|
39 |
R7 MODIFY Arg1:T19 Arg2:E11 |
|
|
40 |
T20 Diagnostic_procedure 382 409 Histopathologic examination |
|
|
41 |
E14 Diagnostic_procedure:T20 |
|
|
42 |
T21 Diagnostic_procedure 421 436 biopsy specimen |
|
|
43 |
E15 Diagnostic_procedure:T21 |
|
|
44 |
T22 Biological_structure 415 420 liver |
|
|
45 |
R8 MODIFY Arg1:T22 Arg2:E15 |
|
|
46 |
T23 Therapeutic_procedure 449 460 laparoscopy |
|
|
47 |
E16 Therapeutic_procedure:T23 |
|
|
48 |
R9 MODIFY Arg1:E16 Arg2:E15 |
|
|
49 |
T24 Disease_disorder 498 509 cholangitis |
|
|
50 |
E17 Disease_disorder:T24 |
|
|
51 |
T25 Detailed_description 470 485 non-suppurative |
|
|
52 |
T26 Detailed_description 486 497 destructive |
|
|
53 |
T27 Biological_structure 517 528 portal area |
|
|
54 |
R10 MODIFY Arg1:T26 Arg2:E17 |
|
|
55 |
R11 MODIFY Arg1:T25 Arg2:E17 |
|
|
56 |
R12 MODIFY Arg1:T27 Arg2:E17 |
|
|
57 |
T28 Disease_disorder 559 562 PBC |
|
|
58 |
E18 Disease_disorder:T28 |
|
|
59 |
T29 Disease_disorder 564 579 Scheuer stage 3 |
|
|
60 |
E19 Disease_disorder:T29 |
|
|
61 |
R13 MODIFY Arg1:E19 Arg2:E18 |
|
|
62 |
T30 Medication 599 619 ursodeoxycholic acid |
|
|
63 |
E20 Medication:T30 |
|
|
64 |
T31 Dosage 621 627 900 mg |
|
|
65 |
T32 Frequency 628 633 daily |
|
|
66 |
T33 Date 651 672 January and June 2002 |
|
|
67 |
E21 Date:T33 |
|
|
68 |
T35 Therapeutic_procedure 696 724 endoscopic variceal ligation |
|
|
69 |
E23 Therapeutic_procedure:T35 |
|
|
70 |
T36 Therapeutic_procedure 730 764 endoscopic injection sclerotherapy |
|
|
71 |
E24 Therapeutic_procedure:T36 |
|
|
72 |
T37 Therapeutic_procedure 776 800 argon plasma coagulation |
|
|
73 |
E25 Therapeutic_procedure:T37 |
|
|
74 |
T38 Sign_symptom 815 833 esophageal varices |
|
|
75 |
E26 Sign_symptom:T38 |
|
|
76 |
T39 Severity 805 814 worsening |
|
|
77 |
R14 MODIFY Arg1:T39 Arg2:E26 |
|
|
78 |
T40 Date 838 852 September 2007 |
|
|
79 |
E27 Date:T40 |
|
|
80 |
T41 Clinical_event 870 878 admitted |
|
|
81 |
E28 Clinical_event:T41 |
|
|
82 |
T42 Sign_symptom 910 928 esophageal varices |
|
|
83 |
E29 Sign_symptom:T42 |
|
|
84 |
T43 Severity 900 909 recurrent |
|
|
85 |
R15 MODIFY Arg1:T43 Arg2:E29 |
|
|
86 |
T44 Diagnostic_procedure 934 948 platelet count |
|
|
87 |
E30 Diagnostic_procedure:T44 |
|
|
88 |
T45 Lab_value 968 978 52 × 109/L |
|
|
89 |
T46 Lab_value 983 993 69 × 109/L |
|
|
90 |
R16 MODIFY Arg1:T45 Arg2:E30 |
|
|
91 |
R17 MODIFY Arg1:T46 Arg2:E30 |
|
|
92 |
T47 Duration 998 1011 several years |
|
|
93 |
E31 Duration:T47 |
|
|
94 |
R18 MODIFY Arg1:E31 Arg2:E30 |
|
|
95 |
T48 Lab_value 1033 1041 decrease |
|
|
96 |
T49 Lab_value 1047 1057 61 × 109/L |
|
|
97 |
T50 Date 1061 1070 June 2007 |
|
|
98 |
E32 Date:T50 |
|
|
99 |
T51 Lab_value 1074 1083 8 × 109/L |
|
|
100 |
T52 Date 1084 1105 just before admission |
|
|
101 |
E33 Date:T52 |
|
|
102 |
T53 Coreference 1017 1019 it |
|
|
103 |
E34 Coreference:T53 |
|
|
104 |
R19 IDENTICAL Arg1:E34 Arg2:E30 |
|
|
105 |
T54 Sign_symptom 1135 1151 thrombocytopenia |
|
|
106 |
E35 Sign_symptom:T54 |
|
|
107 |
T55 Detailed_description 1118 1131 deterioration |
|
|
108 |
R20 MODIFY Arg1:T55 Arg2:E35 |
|
|
109 |
T56 Disease_disorder 1172 1191 infectious diseases |
|
|
110 |
E36 Disease_disorder:T56 |
|
|
111 |
A1 POLARITY E36 NEG |
|
|
112 |
T57 Medication 1214 1224 medication |
|
|
113 |
E37 Medication:T57 |
|
|
114 |
A2 POLARITY E37 NEG |
|
|
115 |
T58 Date 1229 1238 admission |
|
|
116 |
E38 Date:T58 |
|
|
117 |
T59 Sign_symptom 1264 1271 purpura |
|
|
118 |
E39 Sign_symptom:T59 |
|
|
119 |
A3 POLARITY E39 NEG |
|
|
120 |
T60 Sign_symptom 1276 1293 bleeding episodes |
|
|
121 |
E40 Sign_symptom:T60 |
|
|
122 |
A4 POLARITY E40 NEG |
|
|
123 |
T61 Diagnostic_procedure 1347 1376 platelet-associated IgG level |
|
|
124 |
E41 Diagnostic_procedure:T61 |
|
|
125 |
T62 Lab_value 1390 1394 high |
|
|
126 |
T63 Detailed_description 1381 1389 markedly |
|
|
127 |
R21 MODIFY Arg1:T63 Arg2:T62 |
|
|
128 |
R22 MODIFY Arg1:T62 Arg2:E41 |
|
|
129 |
T64 Diagnostic_procedure 1408 1414 biopsy |
|
|
130 |
E42 Diagnostic_procedure:T64 |
|
|
131 |
T65 Biological_structure 1396 1407 Bone marrow |
|
|
132 |
R23 MODIFY Arg1:T65 Arg2:E42 |
|
|
133 |
T66 Sign_symptom 1424 1444 normocellular marrow |
|
|
134 |
E43 Sign_symptom:T66 |
|
|
135 |
T67 Sign_symptom 1453 1468 cellular atypia |
|
|
136 |
E44 Sign_symptom:T67 |
|
|
137 |
A5 POLARITY E44 NEG |
|
|
138 |
T68 Diagnostic_procedure 1470 1485 Ultrasonography |
|
|
139 |
E45 Diagnostic_procedure:T68 |
|
|
140 |
T69 Diagnostic_procedure 1490 1516 magnetic resonance imaging |
|
|
141 |
E46 Diagnostic_procedure:T69 |
|
|
142 |
T70 Sign_symptom 1528 1537 cirrhotic |
|
|
143 |
E47 Sign_symptom:T70 |
|
|
144 |
T71 Biological_structure 1538 1543 liver |
|
|
145 |
R24 MODIFY Arg1:T71 Arg2:E47 |
|
|
146 |
T72 Sign_symptom 1549 1561 splenomegaly |
|
|
147 |
E48 Sign_symptom:T72 |
|
|
148 |
T73 Sign_symptom 1563 1570 ascites |
|
|
149 |
E49 Sign_symptom:T73 |
|
|
150 |
T74 Sign_symptom 1576 1586 gallstones |
|
|
151 |
E50 Sign_symptom:T74 |
|
|
152 |
T75 Diagnostic_procedure 1592 1603 spleen size |
|
|
153 |
E51 Diagnostic_procedure:T75 |
|
|
154 |
T76 Lab_value 1617 1626 unchanged |
|
|
155 |
R25 MODIFY Arg1:T76 Arg2:E51 |
|
|
156 |
T77 Detailed_description 1632 1640 previous |
|
|
157 |
T78 Diagnostic_procedure 1641 1661 imaging examinations |
|
|
158 |
E52 Diagnostic_procedure:T78 |
|
|
159 |
R26 MODIFY Arg1:T77 Arg2:E52 |
|
|
160 |
R27 MODIFY Arg1:E52 Arg2:T76 |
|
|
161 |
T79 Disease_disorder 1707 1710 PBC |
|
|
162 |
E53 Disease_disorder:T79 |
|
|
163 |
T80 Disease_disorder 1712 1741 decompensated liver cirrhosis |
|
|
164 |
E54 Disease_disorder:T80 |
|
|
165 |
T81 Disease_disorder 1748 1751 ITP |
|
|
166 |
E55 Disease_disorder:T81 |
|
|
167 |
T82 Diagnostic_procedure 1767 1807 Human leukocyte antigen (HLA) genotyping |
|
|
168 |
E56 Diagnostic_procedure:T82 |
|
|
169 |
T83 Diagnostic_procedure 1822 1871 polymerase chain reaction-sequencing-based typing |
|
|
170 |
E57 Diagnostic_procedure:T83 |
|
|
171 |
T84 Diagnostic_procedure 1875 1926 polymerase chain reaction-sequence specific primers |
|
|
172 |
E58 Diagnostic_procedure:T84 |
|
|
173 |
R28 SUB_PROCEDURE Arg1:E57 Arg2:E56 |
|
|
174 |
R29 SUB_PROCEDURE Arg1:E58 Arg2:E56 |
|
|
175 |
T85 Sign_symptom 1962 1972 A*02010101 |
|
|
176 |
E59 Sign_symptom:T85 |
|
|
177 |
T86 Sign_symptom 1974 1982 B*400201 |
|
|
178 |
E60 Sign_symptom:T86 |
|
|
179 |
T87 Sign_symptom 1984 1992 C*030401 |
|
|
180 |
E61 Sign_symptom:T87 |
|
|
181 |
T88 Sign_symptom 1994 2004 C*07020101 |
|
|
182 |
E62 Sign_symptom:T88 |
|
|
183 |
T89 Sign_symptom 2006 2015 DPB1*0501 |
|
|
184 |
E63 Sign_symptom:T89 |
|
|
185 |
T90 Sign_symptom 2017 2026 DQA1*0103 |
|
|
186 |
E64 Sign_symptom:T90 |
|
|
187 |
T91 Sign_symptom 2028 2039 DQA1*030101 |
|
|
188 |
E65 Sign_symptom:T91 |
|
|
189 |
T92 Sign_symptom 2041 2052 DQB1*030201 |
|
|
190 |
E66 Sign_symptom:T92 |
|
|
191 |
T93 Sign_symptom 2054 2065 DQB1*060101 |
|
|
192 |
E67 Sign_symptom:T93 |
|
|
193 |
T94 Sign_symptom 2067 2078 DRB1*080201 |
|
|
194 |
E68 Sign_symptom:T94 |
|
|
195 |
T95 Sign_symptom 2084 2095 DRB1*080302 |
|
|
196 |
E69 Sign_symptom:T95 |
|
|
197 |
T96 Diagnostic_procedure 2101 2121 13C urea breath test |
|
|
198 |
E70 Diagnostic_procedure:T96 |
|
|
199 |
T97 Diagnostic_procedure 2126 2144 H pylori infection |
|
|
200 |
E71 Diagnostic_procedure:T97 |
|
|
201 |
R30 SUB_PROCEDURE Arg1:E70 Arg2:E71 |
|
|
202 |
T98 Lab_value 2149 2157 negative |
|
|
203 |
R31 MODIFY Arg1:T98 Arg2:E71 |
|
|
204 |
T99 Medication 2201 2213 prednisolone |
|
|
205 |
E72 Medication:T99 |
|
|
206 |
T100 Administration 2196 2200 Oral |
|
|
207 |
R32 MODIFY Arg1:T100 Arg2:E72 |
|
|
208 |
T101 Dosage 2215 2220 30 mg |
|
|
209 |
T102 Frequency 2221 2226 daily |
|
|
210 |
T103 Coreference 2232 2235 ITP |
|
|
211 |
E73 Coreference:T103 |
|
|
212 |
R33 IDENTICAL Arg1:E73 Arg2:E55 |
|
|
213 |
T104 Date 2251 2257 day 11 |
|
|
214 |
E74 Date:T104 |
|
|
215 |
T105 Medication 2263 2279 diuretic therapy |
|
|
216 |
E75 Medication:T105 |
|
|
217 |
T106 Medication 2294 2310 albumin infusion |
|
|
218 |
E76 Medication:T106 |
|
|
219 |
R34 CAUSE Arg1:E73 Arg2:E72 |
|
|
220 |
T107 Sign_symptom 2315 2322 ascites |
|
|
221 |
E77 Sign_symptom:T107 |
|
|
222 |
R35 CAUSE Arg1:E77 Arg2:E76 |
|
|
223 |
R36 CAUSE Arg1:E77 Arg2:E75 |
|
|
224 |
T108 Diagnostic_procedure 2345 2359 platelet count |
|
|
225 |
E78 Diagnostic_procedure:T108 |
|
|
226 |
T109 Lab_value 2360 2384 did not increase notably |
|
|
227 |
R37 MODIFY Arg1:T109 Arg2:E78 |
|
|
228 |
T110 Medication 2386 2399 pulse therapy |
|
|
229 |
E79 Medication:T110 |
|
|
230 |
T111 Administration 2405 2416 intravenous |
|
|
231 |
T112 Medication 2417 2435 methylprednisolone |
|
|
232 |
E80 Medication:T112 |
|
|
233 |
R38 MODIFY Arg1:T111 Arg2:E80 |
|
|
234 |
T113 Dosage 2437 2440 1 g |
|
|
235 |
T114 Frequency 2441 2446 daily |
|
|
236 |
T115 Duration 2461 2471 d 22 to 24 |
|
|
237 |
E81 Duration:T115 |
|
|
238 |
T116 Coreference 2486 2494 response |
|
|
239 |
E82 Coreference:T116 |
|
|
240 |
R40 IDENTICAL Arg1:E82 Arg2:E78 |
|
|
241 |
T117 Lab_value 2499 2503 weak |
|
|
242 |
R41 MODIFY Arg1:T117 Arg2:E82 |
|
|
243 |
T118 Detailed_description 2508 2517 temporary |
|
|
244 |
R42 MODIFY Arg1:T118 Arg2:E82 |
|
|
245 |
T119 Date 2522 2526 d 31 |
|
|
246 |
E83 Date:T119 |
|
|
247 |
T120 Sign_symptom 2533 2539 melena |
|
|
248 |
E84 Sign_symptom:T120 |
|
|
249 |
T121 Severity 2528 2532 mild |
|
|
250 |
R43 MODIFY Arg1:T121 Arg2:E84 |
|
|
251 |
T122 Medication 2601 2630 immune gamma globulin therapy |
|
|
252 |
E85 Medication:T122 |
|
|
253 |
T123 Administration 2589 2600 intravenous |
|
|
254 |
R44 MODIFY Arg1:T123 Arg2:E85 |
|
|
255 |
T124 Detailed_description 2580 2585 trial |
|
|
256 |
R45 MODIFY Arg1:T124 Arg2:E85 |
|
|
257 |
T125 Dosage 2632 2636 25 g |
|
|
258 |
T126 Frequency 2637 2642 daily |
|
|
259 |
R46 MODIFY Arg1:T126 Arg2:E85 |
|
|
260 |
T127 Duration 2647 2657 d 32 to 36 |
|
|
261 |
E86 Duration:T127 |
|
|
262 |
T128 Medication 2703 2735 methylprednisolone pulse therapy |
|
|
263 |
E87 Medication:T128 |
|
|
264 |
T129 Administration 2691 2702 intravenous |
|
|
265 |
T130 Detailed_description 2675 2687 second round |
|
|
266 |
R47 MODIFY Arg1:T130 Arg2:E87 |
|
|
267 |
R48 MODIFY Arg1:T129 Arg2:E87 |
|
|
268 |
T131 Duration 2739 2749 d 32 to 34 |
|
|
269 |
E88 Duration:T131 |
|
|
270 |
T132 Coreference 2770 2778 response |
|
|
271 |
E89 Coreference:T132 |
|
|
272 |
T133 Diagnostic_procedure 2829 2843 platelet count |
|
|
273 |
E90 Diagnostic_procedure:T133 |
|
|
274 |
R49 IDENTICAL Arg1:E89 Arg2:E78 |
|
|
275 |
T134 Lab_value 2761 2769 moderate |
|
|
276 |
R50 MODIFY Arg1:T134 Arg2:E89 |
|
|
277 |
T135 Medication 2793 2805 prednisolone |
|
|
278 |
E91 Medication:T135 |
|
|
279 |
T136 Clinical_event 2810 2819 continued |
|
|
280 |
E92 Clinical_event:T136 |
|
|
281 |
R51 MODIFY Arg1:E92 Arg2:E91 |
|
|
282 |
T137 Lab_value 2844 2860 increased slowly |
|
|
283 |
R52 MODIFY Arg1:T137 Arg2:E90 |
|
|
284 |
T138 Sign_symptom 2866 2904 ascites was relatively well controlled |
|
|
285 |
E93 Sign_symptom:T138 |
|
|
286 |
T139 Medication 2910 2919 diuretics |
|
|
287 |
E94 Medication:T139 |
|
|
288 |
R53 CAUSE Arg1:E94 Arg2:E93 |
|
|
289 |
T140 Clinical_event 2923 2932 discharge |
|
|
290 |
E95 Clinical_event:T140 |
|
|
291 |
T141 Disease_disorder 2950 2979 decompensated liver cirrhosis |
|
|
292 |
E96 Disease_disorder:T141 |
|
|
293 |
T142 Diagnostic_procedure 2988 3002 platelet count |
|
|
294 |
E97 Diagnostic_procedure:T142 |
|
|
295 |
T143 Clinical_event 3047 3056 follow-up |
|
|
296 |
E98 Clinical_event:T143 |
|
|
297 |
T144 Sign_symptom 3060 3078 esophageal varices |
|
|
298 |
E99 Sign_symptom:T144 |
|
|
299 |
T145 Therapeutic_procedure 3087 3118 prophylactic endoscopic therapy |
|
|
300 |
E100 Therapeutic_procedure:T145 |
|
|
301 |
A6 POLARITY E100 NEG |
|
|
302 |
R54 MODIFY Arg1:T4 Arg2:E1 |
|
|
303 |
* OVERLAP E1 E2 E3 |
|
|
304 |
R55 AFTER Arg1:E3 Arg2:E6 |
|
|
305 |
R56 AFTER Arg1:E6 Arg2:E4 |
|
|
306 |
* OVERLAP E4 E5 |
|
|
307 |
R57 BEFORE Arg1:E5 Arg2:E7 |
|
|
308 |
* OVERLAP E7 E8 E9 E10 E12 E14 E15 E17 E18 |
|
|
309 |
R58 MODIFY Arg1:T31 Arg2:E20 |
|
|
310 |
R59 MODIFY Arg1:T32 Arg2:E20 |
|
|
311 |
R60 BEFORE Arg1:E18 Arg2:E20 |
|
|
312 |
R61 BEFORE Arg1:E20 Arg2:E21 |
|
|
313 |
R63 BEFORE Arg1:E26 Arg2:E27 |
|
|
314 |
* OVERLAP E27 E28 E29 |
|
|
315 |
R64 AFTER Arg1:E29 Arg2:E30 |
|
|
316 |
R65 BEFORE Arg1:E30 Arg2:E34 |
|
|
317 |
R66 MODIFY Arg1:T48 Arg2:E34 |
|
|
318 |
R67 MODIFY Arg1:T49 Arg2:E34 |
|
|
319 |
R68 MODIFY Arg1:E32 Arg2:T49 |
|
|
320 |
R69 MODIFY Arg1:T51 Arg2:E34 |
|
|
321 |
R70 MODIFY Arg1:E33 Arg2:T51 |
|
|
322 |
R71 BEFORE Arg1:E34 Arg2:E32 |
|
|
323 |
R72 BEFORE Arg1:E32 Arg2:E33 |
|
|
324 |
* OVERLAP E33 E35 |
|
|
325 |
R73 AFTER Arg1:E35 Arg2:E36 |
|
|
326 |
* OVERLAP E36 E37 |
|
|
327 |
R74 BEFORE Arg1:E37 Arg2:E38 |
|
|
328 |
* OVERLAP E38 E39 E40 E41 E42 E43 E44 E45 E46 E47 E48 E49 E50 E51 |
|
|
329 |
R75 BEFORE Arg1:E51 Arg2:E53 |
|
|
330 |
R76 IDENTICAL Arg1:E53 Arg2:E54 |
|
|
331 |
* OVERLAP E53 E55 E56 E59 E60 E61 E62 E63 E64 E65 E66 E67 E68 E69 E70 |
|
|
332 |
R77 BEFORE Arg1:E70 Arg2:E72 |
|
|
333 |
R78 MODIFY Arg1:T101 Arg2:E72 |
|
|
334 |
R79 MODIFY Arg1:T102 Arg2:E72 |
|
|
335 |
* OVERLAP E72 E74 E75 E76 |
|
|
336 |
R80 BEFORE Arg1:E76 Arg2:E78 |
|
|
337 |
* OVERLAP E78 E79 E80 E81 |
|
|
338 |
R39 MODIFY Arg1:T113 Arg2:E80 |
|
|
339 |
R81 MODIFY Arg1:T114 Arg2:E80 |
|
|
340 |
R82 BEFORE Arg1:E81 Arg2:E82 |
|
|
341 |
R83 BEFORE Arg1:E82 Arg2:E83 |
|
|
342 |
R84 MODIFY Arg1:T125 Arg2:E85 |
|
|
343 |
* OVERLAP E83 E84 |
|
|
344 |
R85 BEFORE Arg1:E84 Arg2:E85 |
|
|
345 |
* OVERLAP E85 E86 E87 E88 |
|
|
346 |
R86 BEFORE Arg1:E88 Arg2:E89 |
|
|
347 |
* OVERLAP E89 E91 E90 |
|
|
348 |
R87 BEFORE Arg1:E90 Arg2:E93 |
|
|
349 |
* OVERLAP E93 E95 E96 E97 |
|
|
350 |
R88 MODIFY Arg1:E99 Arg2:E98 |
|
|
351 |
R89 BEFORE Arg1:E97 Arg2:E98 |
|
|
352 |
* OVERLAP E98 E100 |
|
|
353 |
* OVERLAP E21 E23 E24 E25 E26 |